Praxis Precision Medicines, Inc. (PRAX)
250.33
-2.92
(-1.15%)
USD |
NASDAQ |
Jun 09, 16:00
245.00
-5.33
(-2.13%)
After-Hours: 20:00
Praxis Precision Medicines Research and Development Expense (Quarterly) : 77.99M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Spyre Therapeutics, Inc. | 60.41M |
| ADMA Biologics, Inc. | 2.597M |
| Palisade Bio, Inc. | 6.397M |
| Nuvalent, Inc. | 83.61M |
| Heron Therapeutics, Inc. | 2.385M |